Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing.

BACKGROUND Chronic opioid therapy for pain management has increased dramatically without adequate study of potential deleterious effects on breathing during sleep. METHODS A retrospective cohort study comparing 60 patients taking chronic opioids matched for age, sex, and body mass index with 60 patients not taking opioids was conducted to determine the effect of morphine dose equivalent on breathing patterns during sleep. RESULTS The apnea-hypopnea index was greater in the opioid group (43.5/h vs 30.2/h, p < .05) due to increased central apneas (12.8/h vs 2.1/h; p < .001). Arterial oxygen saturation (SpO2) in the opioid group was significantly lower during both wakefulness (difference 2.1%, p < .001) and non-rapid eye movement (NREM) sleep (difference 2.2%, p < .001) but not during rapid eye movement (REM) sleep (difference 1.2%) than in the nonopioid group. Within the opioid group, and after controlling for body mass index, age, and sex, there was a dose-response relationship between morphine dose equivalent and apnea-hypopnea (p < .001), obstructive apnea (p < .001), hypopnea (p < .001), and central apnea indexes (p < .001). Body mass index was inversely related to apnea-hypopnea index severity in the opioid group. Ataxic or irregular breathing during NREM sleep was also more prevalent in patients who chronically used opioids (70% vs 5.0%, p < .001) and more frequent (92%) at a morphine dose equivalent of 200 mg or higher (odds ratio = 15.4, p = .017). CONCLUSIONS There is a dose-dependent relationship between chronic opioid use and the development of a peculiar pattern of respiration consisting of central sleep apneas and ataxic breathing. Although potentially significant, the clinical relevance of these observations remains to be established.

[1]  J. Weil.  Chapter 20 – Respiratory Physiology: Sleep at High Altitudes , 2005 .

[2]  J. Trinder,et al.  Ventilatory instability during sleep onset in individuals with high peripheral chemosensitivity. , 1999, Journal of applied physiology.

[3]  J. Trinder,et al.  Interaction of chemical and state effects on ventilation during sleep onset. , 1996, Journal of applied physiology.

[4]  C. Sullivan,et al.  Pathophysiology of sleep apnea , 1984 .

[5]  P. Staats,et al.  Incidence of Constipation Associated with Long-acting Opioid Therapy: A Comparative Study , 2004, Southern medical journal.

[6]  O. Drummer,et al.  Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients. , 2005, Chest.

[7]  Roger Chou,et al.  Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. , 2003, Journal of pain and symptom management.

[8]  M. Dealberto,et al.  Factors related to sleep apnea syndrome in sleep clinic patients. , 1994, Chest.

[9]  M. Tryba,et al.  Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain , 1996, Pain.

[10]  Christine A. Vandebeek,et al.  Increased Tidal Volume Variability in Children is a Better Marker of Opioid-Induced Respiratory Depression than Decreased Respiratory Rate , 2003, Journal of Clinical Monitoring and Computing.

[11]  R. Portenoy,et al.  Opioid therapy for chronic nonmalignant pain: a review of the critical issues. , 1996, Journal of pain and symptom management.

[12]  E. Caravati,et al.  Increase in poisoning deaths caused by non-illicit drugs--Utah, 1991-2003 , 2005 .

[13]  E. Wolpert.  A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[14]  K. Burgess,et al.  Central and obstructive sleep apnoea during ascent to high altitude , 2004, Respirology.

[15]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[16]  A. Rechtschaffen.  A manual of standardized terminology, techniques and scoring system for sleep of human subjects , 1968 .

[17]  Kazuhiko Fukuda,et al.  Proposed supplements and amendments to ‘A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects’, the Rechtschaffen & Kales (1968) standard , 2001, Psychiatry and clinical neurosciences.

[18]  T. V. Santiago,et al.  Control of breathing during methadone addiction. , 1977, The American journal of medicine.

[19]  J. Bruhn,et al.  Opioid-induced respiratory depression is associated with increased tidal volume variability , 2003, European journal of anaesthesiology.

[20]  J. L. Dahl,et al.  Trends in medical use and abuse of opioid analgesics. , 2000, JAMA.

[21]  G. Bowes,et al.  Arousal responses to respiratory stimuli during sleep , 1984 .

[22]  D. White,et al.  Central sleep apnea. , 1985, The Medical clinics of North America.

[23]  M. Mccaffery,et al.  Pain : clinical manual , 1999 .

[24]  F. Fulfaro,et al.  Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  I. Kronborg,et al.  Sleep-disordered breathing in stable methadone programme patients: a pilot study. , 2001, Addiction.

[26]  T. V. Santiago,et al.  Respiratory consequences of methadone: the response to added resistance to breathing. , 1980, The American review of respiratory disease.

[27]  D. Lussier.  Use of Opioids for Chronic Pain , 2004 .

[28]  L. Maguire,et al.  Prevention of narcotic-induced constipation. , 1981, The New England journal of medicine.

[29]  O. Drummer,et al.  Central sleep apnea in stable methadone maintenance treatment patients. , 2005, Chest.

[30]  R. Farney,et al.  Sleep-disordered breathing associated with long-term opioid therapy. , 2003, Chest.